These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 2806815)

  • 1. [Survival of a cohort of 418 patients with ascitic cirrhosis].
    Launoy G; Pottier D; Dao T; Tuyns A; Valla A; Gignoux M
    Gastroenterol Clin Biol; 1989; 13(8-9):750-1. PubMed ID: 2806815
    [No Abstract]   [Full Text] [Related]  

  • 2. [Survival of ascitic alcoholic cirrhosis patients. Comparison of results from 3 surveys during a 20-year period].
    Justin-Besançon L; Durand H; Dorfmann H; Gueroult N; Voisin PM; Roge J; Etienne JP
    Ann Med Interne (Paris); 1971 Jan; 122(1):49-54. PubMed ID: 5548149
    [No Abstract]   [Full Text] [Related]  

  • 3. Clinical characteristics and outcome of patients with cirrhosis and refractory ascites.
    Moreau R; Delègue P; Pessione F; Hillaire S; Durand F; Lebrec D; Valla DC
    Liver Int; 2004 Oct; 24(5):457-64. PubMed ID: 15482343
    [TBL] [Abstract][Full Text] [Related]  

  • 4. External validation of a prognostic model for predicting survival of cirrhotic patients with refractory ascites.
    Guardiola J; Baliellas C; Xiol X; Fernandez Esparrach G; Ginès P; Ventura P; Vazquez S
    Am J Gastroenterol; 2002 Sep; 97(9):2374-8. PubMed ID: 12358259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pathophysiology, diagnosis and treatment of ascites in cirrhosis.
    Uriz J; Cárdenas A; Arroyo V
    Baillieres Best Pract Res Clin Gastroenterol; 2000 Dec; 14(6):927-43. PubMed ID: 11139347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites.
    Kurt M
    Hepatology; 2011 Apr; 53(4):1411-2. PubMed ID: 21225642
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment with colchicine and survival of patients with ascitic cirrhosis: a double-blind randomized trial.
    Adhami JE; Basho J
    Panminerva Med; 1998 Mar; 40(1):75-81. PubMed ID: 9573762
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Embolization of hepatic artery in liver cirrhosis complicated by ascites: long-term results].
    Tarazov PG
    Khirurgiia (Mosk); 1999; (4):18-21. PubMed ID: 10234903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognosis assessment of cirrhotic patients with refractory ascites treated with a peritoneovenous shunt.
    Guardiola J; Xiol X; Escribá JM; Castellví JM; Castellote J; Baliellas C; Rafecas A; Casais LA
    Am J Gastroenterol; 1995 Dec; 90(12):2097-102. PubMed ID: 8540495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistent ascites and low serum sodium identify patients with cirrhosis and low MELD scores who are at high risk for early death.
    Heuman DM; Abou-Assi SG; Habib A; Williams LM; Stravitz RT; Sanyal AJ; Fisher RA; Mihas AA
    Hepatology; 2004 Oct; 40(4):802-10. PubMed ID: 15382176
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver.
    Salerno F; Angeli P; Bernardi M; Laffi G; Riggio O; Salvagnini M
    Ital J Gastroenterol Hepatol; 1999 Oct; 31(7):626-34. PubMed ID: 10604107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental, clinical, and metabolic results of side-to-side portacaval shunt for intractable cirrhotic ascites.
    Orloff MJ; Orloff MS; Orloff SL; Girard B
    J Am Coll Surg; 1997 Jun; 184(6):557-70. PubMed ID: 9179111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Influence of diuretics on the survival of 180 patients with cirrhosis of the liver and ascites].
    Robert M; Portmann B
    Schweiz Med Wochenschr; 1969 Feb; 99(6):178-82. PubMed ID: 5781367
    [No Abstract]   [Full Text] [Related]  

  • 14. [Treatment of intractable ascites in cirrhotic patients by portal shunt].
    Franco D
    Gastroenterol Clin Biol; 1983 May; 7(5):533-9. PubMed ID: 6873567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term outcomes of cirrhosis in nonalcoholic steatohepatitis compared with hepatitis C.
    Hui JM; Kench JG; Chitturi S; Sud A; Farrell GC; Byth K; Hall P; Khan M; George J
    Hepatology; 2003 Aug; 38(2):420-7. PubMed ID: 12883486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized controlled study of TIPS versus paracentesis plus albumin in cirrhosis with severe ascites.
    Salerno F; Merli M; Riggio O; Cazzaniga M; Valeriano V; Pozzi M; Nicolini A; Salvatori F
    Hepatology; 2004 Sep; 40(3):629-35. PubMed ID: 15349901
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Viral liver cirrhosis: natural course, pathogenesis and clinical implications of the complications].
    Gentilini P; Laffi G; La Villa G; Casini-Raggi V; Romanelli RG; Buzzelli G; Mazzanti R; Marra F; Pinzani M; Zignego AL
    Ann Ital Med Int; 1996 Oct; 11 Suppl 2():23S-29S. PubMed ID: 9004817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MELD score as a predictor of nontransplant surgical mortality in patients with cirrhosis.
    Perkins J
    Liver Transpl; 2006 Jan; 12(1):159. PubMed ID: 16382470
    [No Abstract]   [Full Text] [Related]  

  • 19. [Mortality of liver cirrhosis and alcoholism in France from 1950 to 1981].
    Gropetis G; Boisson-Lalliard C; Valleron AJ
    Rev Epidemiol Sante Publique; 1985; 33(6):396-408. PubMed ID: 3832190
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival and prognostic factors of cirrhotic patients with ascites: a study of 134 outpatients.
    Salerno F; Borroni G; Moser P; Badalamenti S; Cassarà L; Maggi A; Fusini M; Cesana B
    Am J Gastroenterol; 1993 Apr; 88(4):514-9. PubMed ID: 8470631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.